Specialty Chemicals company Tatva Chintan Pharma Chem announced Q1FY27 results

Specialty Chemicals company Tatva Chintan Pharma Chem announced Q1FY27 results Consolidated Financial Highlights:

SEBI RA - Sunil Kotak - Shubh Consultancy - INH000015826 Revenue from operations for Q1FY27 stood at Rs 1,670.55 million, representing a YoY increase of 42.95% from Rs 1,168.64 million in Q1FY26 and a QoQ growth of 24.53% from Rs 1,341.44 million in Q4FY26. Total income reached Rs 1,698.35 million in Q1FY27 compared to Rs 1,180.19 million in Q1FY26, registering a YoY growth of 43.91%. Profit before exceptional items and tax for Q1FY27 was Rs 224.29 million, an increase of 146.45% from Rs 91.01 million in Q1FY26 and up 35.22% from Rs 165.87 million in Q4FY26. Net profit for the period (PAT) was reported at Rs 159.81 million in Q1FY27, showing a YoY growth of 140.28% compared to Rs 66.51 million in Q1FY26 and a QoQ increase of 54.84% from Rs 103.21 million in Q4FY26. Basic Earnings Per Share (EPS) for Q1FY27 stood at Rs 6.83, compared to Rs 2.84 in Q1FY26 and Rs 4.41 in Q4FY26. All this is for information. This is not a buy/sell recommendation. Thank you, Technofunda24